Virulence of serotype M3 Group A Streptococcus strains in wax worms (Galleria mellonella larvae).
Group A Streptococcus (GAS) causes human infections that range in severity from pharyngitis ("strep-throat") to necrotizing fasciitis ("flesh-eating disease").  To facilitate investigation of the molecular basis of host-pathogen interactions, infection models capable of rapidly screening for differences in GAS strain virulence are needed.  To this end, we developed a Galleria mellonella larvae (wax worm) model of invasive GAS infection and used it to compare the virulence of serotype M3 GAS strains.  We found that GAS causes severe tissue damage and kills wax worms in a dose-dependent manner.  The virulence of genetically distinct GAS strains was compared by Kaplan-Meier survival analysis and determining 50% lethal doses (LD 50).  Host-pathogen interactions were further characterized using quantitative culture, histopathology and TaqMan assays.  GAS strains known to be highly pathogenic in mice and monkeys caused significantly lower survival and had significantly lower LD 50s in wax worms than GAS strains associated with attenuated virulence or asymptomatic carriage.  Furthermore, isogenic inactivation of proven virulence factors resulted in a significantly increased LD 50 and decreased lesion size compared to the wild-type strain, a finding that also strongly correlates with animal studies.  Importantly, survival analysis and LD 50 determination in wax worms supported our hypothesis that a newly emerged GAS subclone that is epidemiologically associated with more human necrotizing fasciitis cases than its progenitor lineage has significantly increased virulence.  We conclude that GAS virulence in wax worms strongly correlates with the data obtained in vertebrate models, and thus, the Galleria mellonella larva is a useful host organism to study GAS pathogenesis.
The Methodist Hospital Research Institute, Houston, TX, USA. rjolsen@tmhs.org
Randall J
RJ
Olsen
M Ebru
ME
Watkins
Concepcion C
CC
Cantu
Stephen B
SB
Beres
James M
JM
Musser
D000818:Animals; D000942:Antigens, Bacterial / Q000235:genetics; D001425:Bacterial Outer Membrane Proteins / Q000235:genetics; D002352:Carrier Proteins / Q000235:genetics; D002353:Carrier State / Q000382:microbiology; D005838:Genotype; D054884:Host-Pathogen Interactions; D006801:Humans; D007814:Larva / Q000382:microbiology; D007915:Lepidoptera / Q000382:microbiology*; D007928:Lethal Dose 50; D012703:Serotyping; D013290:Streptococcal Infections / Q000382:microbiology; D013297:Streptococcus pyogenes / Q000145:classification / Q000302:isolation & purification / Q000472:pathogenicity*; D016019:Survival Analysis; D014774:Virulence
D000942:Antigens, Bacterial; D001425:Bacterial Outer Membrane Proteins; D002352:Carrier Proteins; C014689:streptococcal M protein
Curr Opin Pharmacol. 2009 Oct;9(5):545-51
19726228
Infect Immun. 2008 Mar;76(3):978-85
18174342
Science. 2004 Aug 27;305(5688):1283-6
15333838
Mycopathologia. 2006 Jun;161(6):377-84
16761185
Infect Immun. 2008 Mar;76(3):1267-75
18195031
J Infect Dis. 2003 Nov 15;188(10):1587-92
14624386
Proc Natl Acad Sci U S A. 2006 May 2;103(18):7059-64
16636287
Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1679-84
15668390
Proc Natl Acad Sci U S A. 2008 Jan 29;105(4):1327-32
18216255
Curr Opin Immunol. 1998 Feb;10(1):23-8
9523106
J Bacteriol. 2006 Jan;188(2):399-408
16385029
Infect Immun. 2005 Jul;73(7):3842-50
15972469
Proc Natl Acad Sci U S A. 2002 Jul 23;99(15):10078-83
12122206
Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4371-6
20142485
Microb Pathog. 2010 Dec;49(6):336-47
20674736
Proc Natl Acad Sci U S A. 2010 Mar 9;107(10):4693-8
20179180
Proc Natl Acad Sci U S A. 2006 May 30;103(22):8487-92
16687478
J Bacteriol. 2000 Jul;182(13):3843-5
10851003
Cell Microbiol. 2009 Jan;11(1):1-12
18710460
PLoS One. 2010 Apr 14;5(4):e9798
20418946
Clin Infect Dis. 2002 Feb 15;34(4):454-60
11797171
Chest. 2006 Dec;130(6):1679-86
17166982
J Infect Dis. 2003 Sep 15;188(6):818-27
12964112
N Engl J Med. 1996 Aug 22;335(8):547-54
8684408
Ann Intern Med. 2007 Aug 21;147(4):234-41
17709757
Gene. 2005 Oct 24;360(1):45-54
16154298
Microbes Infect. 2007 May;9(6):729-34
17400503
Mol Microbiol. 2006 Oct;62(2):339-55
16978259
PLoS Pathog. 2010 Mar 19;6(3):e1000817
20333240
Infect Immun. 2008 Aug;76(8):3399-404
18490458
FEMS Microbiol Rev. 2004 Feb;28(1):101-12
14975532
Antimicrob Agents Chemother. 2009 Jun;53(6):2605-9
19332683
J Insect Physiol. 2000 Jul 1;46(7):1129-1135
10817839
Proc Natl Acad Sci U S A. 2006 Oct 24;103(43):16009-14
17043230
Proc Natl Acad Sci U S A. 2007 May 29;104(22):9451-6
17517606
J Infect Dis. 2009 Feb 15;199(4):532-6
19125671
J Biol Chem. 2004 Dec 10;279(50):52789-96
15466462
PLoS One. 2008;3(12):e4102
19116661
FEMS Immunol Med Microbiol. 2000 Feb;27(2):163-9
10640612
Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10416-21
11517341
Microbes Infect. 2004 Oct;6(12):1117-23
15380782
Proc Natl Acad Sci U S A. 2010 Jan 12;107(2):888-93
20080771
Annu Rev Pathol. 2010;5:1-31
19737105
PLoS One. 2008 Jul 30;3(7):e2785
18665215
Methods Mol Biol. 2008;431:255-67
18287762
Appl Environ Microbiol. 2010 Jan;76(1):310-7
19897755
Lancet Infect Dis. 2005 Nov;5(11):685-94
16253886
Am J Pathol. 2005 Dec;167(6):1461-72
16314461
N Engl J Med. 1989 Jul 6;321(1):1-7
2659990
Contrib Microbiol. 2009;16:103-119
19494581